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Abstract
Protein kinase signaling along the kinetochore-centromere axis is crucial to assure mitotic fidelity, 
yet its spatial coordination is obscure. Here, we examined how pools of human Polo-like kinase 1 
(Plk1) within this axis control signaling events to elicit mitotic functions. To do this, we restricted 
active Plk1 to discrete subcompartments within the kinetochore-centromere axis using chemical 
genetics and decoded functional and phosphoproteomic signatures of each. We observe distinct 
phosphoproteomic and functional roles, suggesting that Plk1 exists and functions in discrete pools 
along this axis. Deep within the centromere, Plk1 operates to assure proper chromosome 
alignment and segregation. Thus, Plk1 at the kinetochore is a conglomerate of an observable bulk 
pool coupled with additional functional pools below the threshold of microscopic detection/
resolution. Although complex, this multiplicity of locales provides an opportunity to decouple 
functional and phosphoproteomic signatures for a comprehensive understanding of Plk1’s 
kinetochore functions.
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Introduction
During mitosis, macromolecular kinetochores assemble upon centromeric chromatin to 
attach chromosomes to spindle microtubules. In addition to its structural role, the 
kinetochore generates signals to promote proper attachment of sister chromatids to opposite 
spindle poles (biorientation) to ensure accurate segregation into daughter cells. Several 
protein kinases regulate kinetochore signaling, including Aurora B, Bub1, BubR1, Mps1, 
Haspin and Polo-like kinase 1 (Plk1)1–3. How these mitotic kinases operate within the 
kinetochore is obscure, but spatial cues are clearly important. For example, one model for 
Aurora B function is based on a tension-generated loss of spatial access to its substrates4,5. It 
is unclear if the spatial distributions of mitotic kinases within the kinetochore control 
accessibility of substrates and functions. Here, we investigated how spatial distribution of 
Plk1 along the kinetochore contributes to its function and access to substrates.
Polo-like kinase 1 (Plk1) is a core regulator of mitosis required for centrosome maturation, 
bipolar spindle formation, chromosome arm resolution, chromosome alignment and 
segregation, and cytokinesis6. Plk1 localizes to several mitotic structures, including 
centrosomes, chromosome arms, kinetochores and the anaphase spindle midzone6,7. Its 
localization is established primarily via its C-terminal Polo-box domain (PBD), a 
phosphopeptide binding domain, which requires its direct binding partner to be primed 
through phosphorylation8,9. Preventing Plk1 localization disrupts its functions, resulting in 
failure to align and segregate chromosomes10–13 and impaired cytokinesis14.
Spatial regulation of Plk1 signaling at the kinetochore remains enigmatic due to a 
multiplicity of interactors and substrates located at distinct sites along the entire 
kinetochore-centromere axis (Supplementary Results, Supplementary Fig. 1). During 
mitosis, Plk1 is recruited to the outer kinetochore by Bub115, NudC16, and BubR1, where it 
phosphorylates BubR117,18 and CLASP19 to stabilize kinetochore-microtubule attachments, 
promoting chromosome alignment, and Kif2b20 to correct microtubule attachment errors, 
facilitating accurate chromosome segregation. At the inner kinetochore, Plk1’s role in 
chromosome alignment and segregation also requires recruitment by and phosphorylation of 
CENP-U/5021 (also called PBIP) and CENP-Q22. Surprisingly, Plk1 is also reported to 
function at the inner centromere, approximately 500 nm from the outer kinetochore, and 
normal chromosome dynamics depend on its binding to INCENP23 and phosphorylation of 
Survivin24,25, members of the chromosome passenger complex (CPC). Microscopically, 
Plk1 is visualized as a single kinetochore focus, and its kinase domain is only 5 nm in 
length26, so it is difficult to envision how it could span ~500 nm to access these substrates. 
The alternative is that multiple pools of Plk1 exist at distinct kinetochore subcompartments. 
If so, we would expect Plk1 kinetochore functions to be separable by precise spatial control 
of its activity.
A detailed understanding of Plk1 signaling at the kinetochore has remained elusive for 
several reasons. First, most previous studies abrogate all Plk1 activity, resulting in 
prometaphase-arrested cells with monopolar spindles. This prevents direct evaluation of 
mitotic activities that require a bipolar spindle, including chromosome alignment, 
segregation, and cytokinesis. Second, Plk1’s localization to multiple mitotic structures 
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necessitates uncoupling its kinetochore activity from other locales27. Finally, 
phosphoproteomic studies have identified hundreds of Plk1-regulated phosphorylation 
sites28–31, but the abundance of substrates has impaired efficient assignment of 
phosphorylation events to biologic functions. To circumvent the first obstacle, we previously 
titrated Plk1 activity to uncouple chromosome alignment and segregation from bipolar 
spindle formation12. Here, we addressed the second and third obstacles through chemical 
genetic complementation, high-resolution microscopy, and quantitative phosphoproteomics. 
These data support the model that Plk1 operates in pools within the kinetochore and, 
surprisingly, the bulk pool is at the inner kinetochore/centromere. Moreover, Plk1 operates at 
chromatin and in the inner centromere in a manner that is distinct and separable from Plk1’s 
role in stabilizing microtubule attachments at the outer kinetochore17–19. The separability of 
Plk1 operation within the kinetochore provides an opportunity to match functional and 
phosphoproteomic signatures, and to identify phosphorylation events that regulate specific 
aspects of mitotic progression.
Results
Diffusible Plk1 fails to function at the kinetochore
To interrogate Plk1 signaling at the kinetochore, we employed a chemical genetic system 
wherein each of two distinct Plk1 alleles is separately controlled by chemical inhibitors. 
Briefly, human RPE1 cells had the endogenous PLK1 exon 3 deleted and rescued by GFP-
Plk1as, which encodes chemical sensitivity to 3-methylbenzyl-pyrazolopyrimidine (3-MB-
PP1) through two point mutations32. When wild type Plk1 (Plk1wt) is co-expressed in cells 
with Plk1as, these complement, and either allele can execute the essential functions of this 
kinase. However, Plk1wt and Plk1as are separately controlled: Plk1wt is sensitive to the 
pharmacologic inhibitor, BI-2536 and resistant to 3-MB-PP1, whereas Plk1as is resistant to 
BI-253633 (Fig. 1a). This empowers exquisite spatial and temporal control of Plk1 activity 
along the kinetochore-centromere axis.
Plk1 signaling at the kinetochore might not require localization to exert its functions. To test 
this, we generated lines that stably co-express GFP-Plk1as and either Plk1wt, or Plk1aa, 
which has a wild type kinase domain but is delocalized by virtue of a mutant PBD (Fig. 1b). 
The PBD of Plk1aa has two point mutations (H538A/K540M)—sufficient to disrupt Plk1 
localization8,14. For the delocalized construct, we used either N-terminal Flag tag (Plk1aa) or 
mCherry tag (Ch-Plk1aa) (Fig. 1b). Both are expressed and exhibit catalytic activity similar 
to Plk1wt (Supplementary Fig. 2a-b). As expected, neither localize to kinetochores, 
centrosomes, or the spindle midzone (Supplementary Fig. 2c), yet both partially restore 
bipolar spindles (Supplementary Fig. 2d-e), consistent with previous findings10,12.
We previously titrated low inhibitor concentrations to observe Plk1 loss-of-function 
phenotypes in which a bipolar spindle is preserved12. Under these conditions chromosomes 
fail to align at the midline, presumably from impaired kinetochore function. As expected, 
Plk1wt restored chromosome alignment (81% vs. 28% with vector, p<0.0001) (Fig. 1c-d). 
With Plk1aa or Ch-Plk1aa, however, chromosome alignment remained impaired (both 26% 
vs. 28% for vector control). Thus, a functional PBD is required for Plk1 to align mitotic 
chromosomes, consistent with earlier reports10,34.
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A second loss-of-function phenotype of Plk1 is lagging anaphase chromosomes, which 
occur at very modest losses of Plk1 activity after chromosome alignment on a bipolar 
spindle and silencing of the mitotic checkpoint12. We tested if delocalized Plk1 was 
sufficient to restore accurate anaphase chromosome segregation. As expected, Plk1wt 
localized and restored chromosome segregation compared to vector cells (94% vs. 47%, 
p<0.0001), yet both Plk1aa and Ch-Plk1aa failed to do so (54% and 40%, respectively) (Fig. 
1e-f). We conclude that PBD-dependent kinase localization is required for both chromosome 
alignment and segregation.
Recapitulating Plk1 at the kinetochore
We next considered how Plk1 localization within the kinetochore might control function. At 
the extremes, Plk1 could bind each substrate directly (focal operation) or it could bind a 
single partner and have sufficient reach to signal throughout the kinetochore (dispersive 
operation). Alternatively, Plk1 could operate between these extremes—binding multiple 
partners with limited dispersiveness to reach adjacent substrates. To test these models, we 
artificially tethered Plk1 to discrete subcompartments within the kinetochore axis, by 
replacing the C-terminal PBD with cDNAs encoding proteins that localize to the outer 
kinetochore (Dsn1), to chromatin (H2B), or to the inner centromere (Kif2c) 
(Supplementary Fig. 3a). These partners had a diversity of localization and were superior 
to other tether partners in localization, expression, or activity. We selected clonal lines in 
which fusion proteins localized appropriately (Supplementary Fig. 3b), with low levels of 
delocalized extractable protein (Supplementary Fig. 3c-e). Typically, the kinetochore-
tethered Plk1 constructs were expressed at lower levels than full-length Plk1 (Plk1wt) but 
had a higher specific activity (Supplementary Fig. 4).
To precisely localize Plk1 and the kinetochore-tethered constructs, we employed high-
resolution microscopy of metaphase cells to map mean positions relative to CENP-I/CENP-
C standards as described previously35,36 (Fig. 2a-b). Surprisingly, endogenous Plk1 mapped 
approximately 37 nm inside of the CENP-I probe, within the inner kinetochore at the 
centromere periphery (Fig. 2c). This finding is unexpected because it spatially isolates bulk 
Plk1 from known outer kinetochore targets, such as CENP-U/50 and BubR1, which mapped 
approximately 64 nm and 80 nm outward from Plk1, respectively (Fig. 2a,c). This 
localization is not an artifact of cell type or antibody as it was similar in HeLa cells and with 
antibodies targeting tagged Plk1 (Supplementary Fig. 5a-d). Moreover, Plk1 localization is 
independent of microtubule attachment as Plk1 remains positioned interior to CENP-C in 
nocodazole-arrested cells (Supplementary Fig. 5e). Thus, wild type Plk1 predominantly 
localizes deep in the inner kinetochore, near chromatin, independent of microtubule 
attachment status.
For tethered constructs, we observed two distinct pools of Plk1ΔC-Kif2c: one in the inner 
centromere, as expected, and a second 34 nm outside the inner kinetochore CENP-C probe, 
near the Ndc80 complex at the outer kinetochore (Fig. 2b-c), consistent with Kif2c at 
microtubule tips36–38. The Plk1ΔC-Dsn1 construct localized an average of 24 nm outside of 
the CENP-C probe, consistent with endogenous Dsn1 localization35,36, validating 
localization of the fusion constructs.
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It was initially unclear whether re-localized kinases could access Plk1 substrates, and if so, 
whether they operate with sufficient dispersiveness to usefully separate function. To assess 
substrates accessed, we evaluated quantitative phosphoproteomic signatures compared to 
Plk1wt and Ch-Plk1aa (Fig. 3). We used 5 constructs: Plk1wt (normal localization) and Ch-
Plk1aa (delocalized) controls, plus kinase tethered to Dsn1 (outer kinetochore), to H2B 
(chromatin), and to Kif2c (inner centromere and microtubule tips). For each, we examined 
phosphoproteomics with tethered/control Plk1 both on (-BI-2536) and off (+BI-2536) for a 
total of 5 cell lines/2 conditions using 10-plex tandem mass tags (TMT)39 (Supplementary 
Fig. 6a). We detected 531 phosphopeptides decreased >2x by inhibition of Plk1wt, 
corresponding to 396 proteins (Fig. 3a, Supplementary Fig. 6b and Supplementary 
Dataset 1), similar to previous Plk1 phosphoproteomic analyses28–31. Of the 531 Plk1-
regulated phosphopeptides, kinetochore-tethered constructs together restored 94 (Fig. 3b-c). 
These 94 phosphopeptides met three criteria: (i) >2x decrease when Plk1wt was inhibited by 
BI; (ii) >2x increase with the tethered construct vs. Plk1wt+BI; (iii) >2x decrease when the 
tethered construct was inhibited with BI. Although some phosphorylation events could be 
indirect, 47 of these 94 phosphopeptides share the Plk1 consensus motif [D/E/N/Q-X-pS/
pT]31, demonstrating many are likely direct and the reach of tethered Plk1 is significant. 
Additionally, there is minimal overlap in phosphopeptides reached by the 3 tethered 
constructs, with 63/119 unique to one construct and only 7 restored by all. Thus tethered 
Plk1 effectively partitions kinase signaling within kinetochore subcompartments.
The phosphopeptides accessed within the kinetochore are largely consistent with the 
localization of constructs (Supplementary Table 1). For example, Plk1ΔC-Dsn1 enhances 
phosphorylation of proteins that interact with microtubules and cytoskeleton, consistent with 
function at the outer kinetochore. Further validating outer-kinetochore activity of this 
construct, it restored Plk1-regulated phosphorylation of Dsn1 itself. By contrast, Plk1ΔC-
H2B regulated phosphorylation of proteins involved in DNA repair and transcription. 
Overlapping phosphopeptides were found between Plk1ΔC-Kif2c with both Plk1ΔC-Dsn1 
and with Plk1ΔC-H2B, consistent with the known localization of Kif2c at both the outer 
kinetochore (near Dsn1) and inner centromere (near chromatin), but no overlap was found 
between Plk1ΔC-Dsn1 and Plk1ΔC-H2B, demonstrating their spatial isolation. We next 
considered phosphopeptides from kinetochore proteins that are likely direct; they match the 
minimal Plk1 (D/E/N/Q-X-pS/pT) consensus (Supplementary Fig. 6c). As expected, Plk1wt 
reached targets at the outer kinetochore (CENPE, CENPF, CDC27), along chromatin 
(KIF4A, ERCC6L/PICH) and at the inner centromere (INCENP). Plk1aa successfully 
phosphorylated proteins both at the outer kinetochore (CENPE, CENPF) and the inner 
centromere (INCENP). This may occur, for example, if low levels of delocalized Plk1 
activity are sufficient to phosphorylate proteins protected from phosphatases. Alternatively, 
delocalized Plk1 could phosphorylate soluble substrates in early mitosis, before kinetochore 
assembly. Surprisingly, Plk1 at the outer kinetochore (Plk1ΔC-Dsn1) failed to target 
kinetochore proteins distinct from Plk1aa. Plk1ΔC-Kif2c targeted some, but not all, proteins 
along the kinetochore-centromere axis. As expected, chromatin-bound Plk1 (Plk1ΔC-H2B) 
was limited to proteins along chromatin (Kif4A, USP16). We conclude that Plk1 localized to 
discrete sites within the kinetochore have restricted regions of activity that overlap 
minimally, yet are sufficiently dispersive to elicit ~40 phosphorylation events each.
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Plk1 operates at chromatin and the inner centromere
To evaluate where Plk1 operates functionally, we tested the kinetochore-tethered constructs 
for complementation. We evaluated chromosome alignment and segregation as in Fig. 1, by 
gently titrating inhibition of Plk1as. Indeed, we found that Kif2c-tethered Plk1, but not 
Dsn1-localized or H2B-localized kinase restored accurate chromosome alignment compared 
to uncomplemented (vector) cells (48% vs. 19%, p<0.0001) (Fig. 4a-b; Supplementary 
Fig. 7a). This rescue was substantial, but incomplete compared to Plk1wt, possibly due to 
insufficient activation of the requisite substrate, or perhaps, complete rescue requires 
additional substrate phosphorylation beyond the tethered construct’s reach. Importantly, this 
rescue was reversed by inhibiting tethered Plk1 with BI-2536 (Fig. 4a), demonstrating that 
activity of re-localized Plk1, not Kif2c expression, facilitates normal alignment. 
Additionally, this is unlikely to arise from a soluble pool of Plk1ΔC-Kif2c because active 
delocalized Plk1aa was unable to rescue (Fig. 1c). We conclude that Kif2c-tethered Plk1 
rescues the chromosome alignment function, either due to activity at microtubule tips or at 
the inner centromere.
Next, we tested anaphase chromosome segregation. As before, Plk1ΔC-Kif2c rescued 
accurate chromosome segregation whereas outer-kinetochore Plk1 (Plk1ΔC-Dsn1) failed to 
do so (Fig. 4c-d, Supplementary Fig. 7b). However, chromatin-localized Plk1 also 
functionally restored chromosome segregation. Again, rescue required active kinase, and 
was reversed with BI-2536 (Fig. 4c). Moreover, soluble Plk1aa was unable to rescue (Fig. 
1e). Tethered constructs did not disrupt chromosome alignment or segregation in the absence 
of inhibition of Plk1as by 3-MB-PP1 (Supplementary Fig. 7c-d). Thus Plk1 acts at either 
chromatin or at Kif2c sites to elicit its function for proper chromosome segregation in 
anaphase. Moreover, the functionally distinct behavior of Plk1ΔC-H2B from Plk1ΔC-Kif2c 
in chromosome alignment suggests that Plk1 phosphorylates one or more unique substrates 
to execute the disparate functions.
Re-evaluating Plk1 function at the outer kinetochore
We identified kinetochore functions that arise from Plk1 signals at chromatin or the inner 
centromere, where the bulk of Plk1 is located. However, outer kinetochore activity could be 
important if Plk1ΔC-Kif2c operates at the microtubule tips, and Plk1ΔC-Dsn1 might fail to 
restore activity merely due to impaired access to key outer kinetochore substrates. To 
address the first question, we separated Plk1ΔC-Kif2c functions at the inner centromere 
versus outer kinetochore. The Kif2c N-terminus is important for inner centromere 
targeting40 and the SxIP sequence within the N-terminus promotes microtubule tip-
tracking37,38 (Supplementary Fig. 8a, top). Using Kif2c localization mutant constructs 
(Supplementary Fig. 8a, bottom), both N-terminal deletion mutant (ΔN) and the 
microtubule tip-tracking mutant (SKNN) were expressed as stable Plk1 fusions and 
exhibited catalytic activity similar to Plk1ΔC-Kif2cwt (Supplementary Fig. 8b-c). As 
expected, the SKNN mutant, but not the ΔN mutant, localized to the inner centromere and 
the SKNN mutant failed to localize at the outer kinetochore (Supplementary Fig. 8d-e). 
Notably, the SKNN, but not the ΔN mutant, rescued both chromosome alignment and 
anaphase chromosome segregation phenotypes, and rescue depended on tethered Plk1 
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activity, as seen by BI-2536-dependent reversal (Fig. 5a-b; Supplementary Fig. 8f-g). 
Thus, Plk1ΔC-Kif2c operates in the inner centromere to execute key mitotic functions.
We next considered that Plk1ΔC-Dsn1, though localized correctly and catalytically active, 
might not access key outer kinetochore substrates. As a measure of Plk1 activity at the outer 
kinetochore, we evaluated BubR1 phosphorylation, which is detectable by a slower 
migrating band on SDS-PAGE18,33. Therefore, we tested BubR1 phosphorylation from 
mitotic extracts, +/− 3-MB-PP1 and found that, indeed, Plk1ΔC-Dsn1 did not reach or only 
weakly phosphorylated BubR1 (Supplementary Fig. 9a). Therefore, we generated 
additional constructs, tethering Plk1 to the outer kinetochore proteins Bub1, BubR1 and 
Hec1 (also called Ndc80). We identified stable cell lines exhibiting diverse expression levels 
including ones expressed at high levels or similar levels to the other tethers with comparable 
catalytic activity (Supplementary Fig. 9b-d). Moreover, the Plk1ΔC-Bub1 and Plk1ΔC-
Hec1 constructs appeared to restore the slow-mobility p-BubR1 band (Supplementary Fig. 
9a). Nevertheless, all three constructs failed to rescue either chromosome alignment or 
segregation (Fig. 5c-f and Supplementary Fig. 9e-f). Together, these data support the idea 
that outer kinetochore Plk1 activity is not required for its function in chromosome alignment 
or segregation. However, we do not exclude the possibility that these four constructs all fail 
to phosphorylate a critical outer kinetochore protein.
Spatially decoding Plk1 phosphoproteomic signatures
Our results afforded the opportunity to decode Plk1 function at the kinetochore by 
phenotypic-phosphoproteomic signature. Heretofore, phosphoproteomic analyses of 
pleiotropic kinases like Plk1 have discovered hundreds of new substrates, yet provided 
limited information to link them to cognate kinase functions. Here, we identified complex 
functional signatures-by-locale for Plk1-dependent phenotypes, which are expected to match 
a limited set of substrates (Fig. 6a). To identify potential substrates, we matched these 
functional signatures with those of phosphopeptides. For example, chromosome alignment is 
restored by Plk1 tethered to Kif2c, but is not restored by delocalized Plk1aa or Plk1 tethered 
to Dsn1 or H2B; only 7 of 176 Plk1-dependent phosphopeptides match this signature (Fig. 
6a, left). Similarly, chromosome segregation is restored with Plk1 localized either to H2B or 
Kif2c, but not to Dsn1 or delocalized Plk1aa; this matches that of only 4 of 146 Plk1-
dependent phosphopeptides (Fig. 6a, right). Because Plk1 operates in specific pools within 
the kinetochore, these data demonstrate that an enlarged set of constructs with restricted 
localization may effectively decode Plk1 function at the kinetochore. This match of 
phosphoproteomic signature with functional signature is an unbiased approach to hone in on 
phosphorylation events that concordantly occur with phenotypic rescue.
Discussion
Here, we identify the functional and phosphoproteomic signatures of Plk1 tethered to 
discrete locales within the centromere, chromatin, and kinetochore. A major finding is that 
Plk1 is predominantly located deep within the kinetochore, where it operates to ensure 
accurate chromosome alignment and segregation. Notably, this localization is independent of 
microtubule attachment, suggesting its presence during early mitosis. Previous work has 
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reported small pools of Plk1 at the inner centromere, where it is activated41. We find that 
Plk1 functions at the inner centromere and at chromatin during mitosis. This finding is 
supported by concordant data, including high-resolution microscopy co-localizing 
endogenous Plk1 with centromeric chromatin, by phosphoproteomic data identifying 
chromatin-bound and inner centromere substrates, and by rescue of Plk1 functions when it is 
artificially tethered to chromatin or to the inner centromere. Although the central binding 
partner of Plk1 at chromatin is unclear, one known partner here is Plk1-Interacting 
Checkpoint Helicase (PICH)42.
We found functional rescue only with active kinase at the chromatin and inner-centromere; 
however, our findings do not exclude the possibility of Plk1 functions outside of this zone. 
Indeed, Plk1 phosphorylation at the outer kinetochore mediates its function in attaching 
chromosomes to the microtubule spindle17,18. Our assays do not capture the outer 
kinetochore functions of Plk1, likely because they are observed with partial loss-of-
function12, in which residual activity may be sufficient to retain phosphorylation of BubR1 
and other outer kinetochore substrates. Moreover, a number of phosphorylations are elicited 
with Plk1 at the outer kinetochore (Fig. 3, Supplementary Table 1). Thus, our findings do 
not conflict with other strong evidence that Plk1 operates at the outer kinetochore17,18,34.
A second key finding of this study is that Plk1 function at the kinetochore can be uncoupled 
at the inner centromere, at chromatin, and at the outer kinetochore, suggesting Plk1 operates 
in distinct pools within the kinetochore (Fig. 6b). A canonical model for Plk1 function is 
that it directly engages substrates through its C-terminal PBD9,43 (Fig. 6b, extreme right), 
and discovery of a new substrate is often coupled with an assay for direct binding (focal 
operation). Consistent with this model, Plk1 is known to bind many substrates within the 
kinetochore, including BubR1 and others16,18,21,42. We are aware of only one counter-
example—endogenous Plk1 engages CENP-U/50 to reach CENP-Q44. Yet, our data 
powerfully demonstrate that direct engagement of substrates via the PBD is not only 
unnecessary, but that it should not be routinely expected. For example, Plk1aa lacks 
phosphopeptide-binding activity, yet phosphorylates 21% of the peptides reached by wild 
type kinase. Second, Plk1 tethered to each discrete kinetochore subcompartment restores 
~40 phosphopeptides (Fig. 3c). Thus, Plk1 function at the kinetochore cannot be accounted 
for solely by a focal model where it engages each substrate directly.
Conversely, Plk1 operation in the kinetochore is not purely dispersive (Fig. 6b, extreme 
left). First, delocalized Plk1aa is incapable of rescuing chromosome alignment or segregation 
(Fig. 1c-f) even though it elicits phosphorylation of more peptides than any tethered 
construct (Fig. 3c). Indeed, the scale from inner centromere to outer kinetochore exceeds the 
~5 nm width of the Plk1 kinase domain26 by two orders of magnitude, making it difficult to 
imagine how a single focus of kinase could reach throughout without at least limited 
diffusion. In addition to the theoretical considerations, we observe minimal overlap of 
phosphoproteomic profiles and ability to rescue Plk1 functions (Figs. 3,4). Thus, our data 
support a pool model, wherein Plk1 engages, perhaps, a small number of interactors that 
allow regional dispersiveness of phosphorylation signals within the kinetochore (Fig. 6b). 
Although a single dominant focus of Plk1 is observed microscopically at each kinetochore, 
this can be explained by limited sensitivity and diffraction limit—some pools, (e.g. outer 
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kinetochore or inner centromere substrates) are not detected or not resolved. Thus, our data 
converge on a model that is complex in that it requires both a diversity of interactors and 
distinct requirements for operation for each pool of Plk1, depending, perhaps, on 
accessibility to phosphatases. A complex interplay of highly regulated kinase and 
phosphatase activities are consistent with recent observations that proper kinetochore 
attachment is regulated by access and activity of phosphatases45–47.
Our tethered Plk1 constructs cannot fully recapitulate dynamic localization, important for 
proper mitosis. For example, during transition from prometaphase to metaphase, CUL3-
KLHL22 ubiquitylation removes Plk1 from the kinetochore48, coincident with decline of 
phosphorylated targets34. Furthermore, non-ubiquitylatable Plk148 and Plk1 tethered to 
Hec134 produce similar aberrant phenotypes—impaired kinetochore-microtubule 
attachments and mitotic delay—suggesting that dampened activity of Plk1 at the outer 
kinetochore is important for proper mitotic progression. We do not exclude a requirement for 
similar dynamics of Plk1 at the inner centromere and chromatin. If removal is required, the 
lack of dynamic activity in our tethered constructs could account for the inability to 
completely restore function. Alternatively, we may have inadvertently mimicked the 
dynamic localization of inner centromere Plk1 because Kif2c is removed at the proper time.
In principle, it is possible that rescue is afforded by phosphorylation of a non-physiologic 
substrate by tethered Plk1; however it is unlikely that chance phosphorylation happens to 
rescue a specific phenotype by a novel mechanism. It is also possible that Plk1 does not 
operate at the inner centromere: although we observe Kif2c at the inner centromere, another 
pool, not readily observable, may exist. Additionally, our conclusions from the 
phosphoproteomic data are limited by the small number of kinetochore peptides detected. 
Indeed, well-documented substrates such as BubR1 are absent from our list. It is possible 
that peptide abundance for these proteins were below our level of detection and different 
protein enrichment strategies may identify additional kinetochore targets which would better 
illuminate the phosphoproteomic signatures of Plk1-tethered constructs. Nevertheless, we 
are able to identify phosphoproteomic evidence of Plk1 function across the kinetochore.
In conclusion, concordant microscopic, phosphoproteomic, and functional evidence places 
Plk1 deep within the kinetochore and centromere where it executes key mitotic functions. 
The data best support a ‘pool model’ of Plk1 function at the kinetochore. Thus, Plk1 exists 
and operates at multiple locations within the kinetochore. For full function, Plk1 needs to 
engage the kinetochore in discrete pools via its PBD, but it need not engage each substrate 
individually. Moreover, such engagement is dispensable altogether for certain 
phosphorylations, such as on CENPE, CENPF or INCENP, which are phosphorylated well 
by soluble kinase. Although this complicated picture challenges our ability to decode 
functions of Plk1 at the kinetochore, it simultaneously provides a tool to meet the challenge
—Plk1 kinase can be restricted to discrete regions of activity within the kinetochore. In 
principle, this approach can decode function of any spatially regulated pleiotropic kinase.
From the molecular point of view, the landscape of a kinetochore is finer than can be 
appreciated by conventional light microscopy. This molecular view is crucial for accurate 
models of molecular signaling within small, complex biologic structures.
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Online Methods
Cell Line Derivation and Culture Procedures
Cell Culture—All cell lines were maintained at 37 °C and 5% CO2 in a humidified 
incubator and propagated in the following media supplemented with 10% fetal bovine serum 
and 100 units/mL penicillin-streptomycin: Phoenix retroviral packaging line, Dulbecco’s 
Modified Eagle’s Medium (DMEM) supplemented with 4.0 mM L-Glutamine and 4500 
mg/L glucose; hTERT-RPE1 derived cell lines, 1:1 mixture of DMEM and Ham’s F-12 
media supplemented with 2.5 mM L-Glutamine. EGFP-Plk1as RPE1 cell lines32 and Plk1as 
cell lines stably expressing mCherry-Plk1 constructs with a “pincer mutant” Polo-Box 
domain (Ch-Plk1aa)12 were derived as previously reported.
Plasmid Construction—All DNA plasmids were cloned into pQCXIN (Clontech) 
retroviral vector. Human Kif2c (MHS1010-73945), Dsn1 (MHS1010-9205748), and Hec1 
(MHS1010-7508250) were purchased from Open Biosystems. Bub1 and BubR1 were gifts 
from B.A. Weaver. Flag-tagged Plk1 constructs with a wild-type (Plk1wt) or pincer mutant 
Polo-Box domain (Plk1aa) were generated by PCR amplification of Plk1 from mCherry-
tagged constructs and cloned into pQCXIN-Flag (pQCFIN) using standard restriction digest 
and ligation procedures. Plk1 fusion constructs were made using a modified USER cloning 
strategy (New England Biolabs). First, the Plk1 kinase domain (Plk1ΔC, 1-1056aa) was PCR 
amplified and inserted into pQCFIN using standard restriction digest and ligation 
procedures. Next, the XbaI restriction site was removed by digest with XbaI, overhang 
removal by T4 DNA polymerase and blunt-end ligation. A 55-base double-stranded USER 
acceptance sequence (Supplementary Table 2) containing XbaI and Nt.BbvCI restriction 
sites was inserted c-terminal to Plk1 (pQCFIN-Plk1ΔC-USER). The plasmid was then 
linearized by XbaI and NtBbvCI digest, creating 8-base overhangs. Kif2c, H2B and Dsn1 
were PCR amplified with primers containing 8-base complementary sequences with a 
terminal uracil. Products were digested with USER enzyme and ligated into pQCFIN-
Plk1ΔC-USER vectors according to manufacturer’s protocol. Kif2c localization mutants 
were made by PCR amplification of amino acids 140-726 (ΔN) or site-directed mutagenesis 
(SKNN) using a QuikChange protocol (Stratagene). Constructs were fully sequenced to 
verify integrity. See Supplementary Table 2 for primer list.
Retroviral Transgenesis—For stable retroviral transduction, constructs were co-
transfected with a VSV-G envelope plasmid into Phoenix cells. Fresh medium was applied 
24 h post-transfection. A further 24 h later, cells were clarified by centrifugation and 
filtration through a 0.45 μm membrane to remove cell debris, and diluted 1:1 with complete 
medium containing 10 μg/ml polybrene (Millipore). Target cells were infected at 40-60% 
confluence for 24 h, then selected with 0.4 mg/ml G418 for 10-14 d. Polyclonal 
transductants were further purified by limiting dilution to obtain individual clones.
Chemicals—Chemicals used in this study include 3-MB-PP1 (Toronto Research 
Chemicals), BI-2536 (Selleck), MG-132 (Enzo Life Sciences), nocodazole and thymidine 
(both EMD Biosciences).
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Immunoblotting, Immunoprecipitation and Kinase Assays
For all experiments, cells were challenged with 0.2 μg/ml nocodazole for 19 h and mitotic 
cells were collected by shakeoff, pelleted, frozen down and stored at −80°C prior to use. 
BubR1 detection included both mitotic and non-mitotic cells after 19 h nocadazole 
treatment.
Immunoblotting—Cell pellets were lysed in buffer (50 mM HEPES pH 7.5, 100 mM 
NaCl, 0.5% NP-40, 10% glycerol) containing phosphatase inhibitors (10 mM sodium 
pyrophosphate, 5 mM β-glycerolphosphate, 50 mM NaF, 0.3 mM Na3VO4), 1mM PMSF, 1x 
protease inhibitor cocktail (Thermo-Scientific) and 1 mM dithiothreitol. Proteins were 
separated by SDS-PAGE, transferred to Immobilon PVDF membrane (Millipore), and 
blocked for 30 min in 4% milk and 0.1% Tween-20 Tris buffered saline ph 7.4 (TBST
+milk). Membranes were incubated with gentle agitation for 2 h at room temperature with 
primary antibodies (Supplementary Table 3) diluted in TBST+milk, washed 3x with TBST, 
incubated for 1 h at room temperature in secondary antibodies conjugated to horse radish 
peroxidase diluted 1:10,000 in TBST+milk. Membranes were washed and developed with 
luminol/peroxide (Millipore) and visualized with film.
All results were obtained from single gels. To simultaneously probe for the protein of 
interest and the loading marker, the membrane was divided in two after transfer and 
incubated in separate antibody solutions. When identical-sized proteins prevented membrane 
division, the membrane was first probed for the protein of interest, stripped in an acidic 
glycine wash (100 mM glycine pH 2, 500 mM NaCl, 2% SDS), rinsed in deionized H2O, 
and then reprobed for the loading marker.
Immunoprecipitation and in vitro kinase assays—Cell lysates were prepared as 
above with up to 1 mg total protein used for pulldown. Protein inputs were adjusted to 
promote equivalent quantities after pulldown. Flag-construct lysates were 
immunoprecipitated with anti-Flag affinity gel (Biotool) for 1 h at 4°C. mCherry-construct 
lysates were incubated for 3 h with 5 μg/mL dsRed antibody, followed by 
immunoprecipitation with a 1:1 mixture protein A and protein G sepharose beads (GE 
Healthcare) for 1 h at 4°C with gentle rotation. The beads/gel were washed three times with 
lysis buffer and then once with kinase buffer (20 mM Tris, pH 7.4, 10 mM MgCl2, 50 mM 
KCl). Fifteen percent of immunoprecipitated complexes were removed for detection of 
bound constructs by Flag or Plk1 immunoblotting. The remainder was then divided and 
incubated in kinase buffer, with or without 200 nM BI-2536, plus 5 μg GST-S (substrate), 10 
μM ATP, 10 mM dithiothreitol and 2.5 μCi [γ-32P] ATP for 40 min at 30°C. 32P 
incorporation was observed by SDS-PAGE and Typhoon TRIO imager (GE Healthcare). 
Three kinase assays were performed from two independent pulldowns. Signal intensity 
quantification was performed in ImageJ49 by calculating area underneath the curve for each 
lane after background subtraction. Final construct intensities were determined by subtracting 
signal with BI-2536 from signal without BI-2536 and expressed as a percentage of the 
control.
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To prepare the Plk1-specific substrate (GST-S) used in the kinase assays, a single nucleic 
acid sequence encoding 6 known, serine-only, Plk1-specific peptide sequences identified 
from PhosphositePlus50 was cloned into the pGEX-6P1 vector (GE Healthcare) by Gibson 
assembly (New England Biolabs). Vector expression was induced in E. coli (BL21DE3) by 
addition of 400 μM IPTG for 3 hours at 37 °C. Bacteria were resuspended in PBS containing 
250 mM NaCl, 10mM EGTA, 10 mM EDTA, 0.1% Tween-20, 1 mM dithiothrietol, 1 mM 
PMSF, and 1 mg/ml lysozyme prior to sonication. GST-S was purified from lysates using 
Glutathione Sepharose 4B beads (GE Healthcare) and eluted in 50 mM Tris-HCL pH 8.0.
Immunofluorescence Microscopy
General procedures—Cells were seeded on glass coverslips at low density in 24-well 
plates and allowed to grow until 80-90% confluence. For chromosome alignment 
experiments, cells were challenged for 2 h with 10 μM MG-132 to prevent anaphase onset 
and 500 nM 3-MB-PP1 ± 200 nM BI-2536. For chromosome segregation experiments, cells 
were challenged for 6 h with 200 nM 3-MB-PP1 ± 200 nM BI-2536. For extraction 
experiments, cells were challenged overnight with 0.2 μg/mL nocodazole.
For pre-extraction, coverslips were initially incubated for 15 s at room temperature (RT) in 
PHEM buffer (60 mM PIPES, 25 mM HEPES, 10 mM EGTA, 2 mM magnesium chloride) 
with 0.5% Triton X-100. Otherwise, coverslips were fixed in 4% paraformaldehyde in 
PHEM buffer for 10 min at RT, washed 3 times in PBS, and then blocked for 30 min at RT 
in 3% bovine serum albumin (BSA) and 0.1% Triton X-100 in PBS (PBSTx+BSA). Primary 
antibodies (Supplementary Table 3) were pooled and diluted in PBSTx+BSA. Coverslips 
were incubated in primary antibodies for 1 h at RT and washed 3 times in PBSTx. Alexa 
Fluor (Invitrogen) secondary antibodies were pooled and diluted at 1:350 in PBSTx+BSA. 
Coverslips were incubated in secondary antibodies for 30 min at RT and then washed twice 
with PBSTx. Coverslips were counterstained with DAPI and mounted on glass slides with 
Prolong Gold anti-fade medium (Invitrogen) and allowed to cure overnight.
Image acquisition was performed on a Nikon Eclipse Ti inverted microscope equipped with 
a 100x/1.4NA (Plan Apo) DIC oil immersion objective, motorized stage (Prior Scientific), 
and CoolSNAP HQ2 CCD camera (Photometrics). Optical sections were taken at 0.2 μm 
intervals and, except for extraction experiments, deconvolved using the AQI 3D 
Deconvolution module in Nikon Elements. Panels were cropped using Photoshop CS5 
(Adobe) and assembled with overlays using Illustrator CS5 (Adobe).
During quantitation of spindle polarity, chromosome alignment and segregation phenotypes, 
observer blinding was performed by slide label concealment. “Bipolar” spindles were 
defined by tubulin staining that exhibited an oval shape, tapered at opposite ends, with 
pericentrin signal at each end. All other spindle types were considered “abnormal”. For 
chromosome alignment, all non-prophase pre-anaphase mitotic cells were included for 
analysis. Cells were scored as exhibiting “aligned” chromosomes if all DNA, visualized by 
DAPI, was present at the cell equator. All other cells were scored as “misaligned”. For 
chromosome segregation, anaphase cells were identified by central spindle localization of 
GFP-Plk1as and chromosome position was determined by DNA (DAPI) and kinetochores 
(ACA antibody) signals. Cells were scored as exhibiting “segregated” chromosomes if no 
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lagging DNA or ACA signals were observed. “Lagging” chromosomes were defined if 
single DNA or ACA signals were observed lagging behind the segregating masses or if the 
two masses were not sufficiently separated despite elongation of the cytoplasm (see Fig. 5, 
panel f, for example).
Quantitation of cytoplasmic fluorescence intensity was performed using Nikon Elements. 
Images of 10 cells were acquired for each condition (‘with extraction’ vs. ‘without 
extraction’ prior to fixation) per Plk1 construct. Threshold levels were equally applied to all 
images to exclude background intensity. Average volume intensity measurements for each 
channel were made using a 1.5×1.5 μm box placed in the cytoplasm of each cell. To 
determine the quantity of construct extracted, the median intensity of the ‘with extraction’ 
cells was subtracted from individual intensities in the ‘without extraction’ cells. These 
values were then divided by the amount of GFP-Plk1as extracted to control for cell-cell 
variability.
Sample size was selected for cell biology experiments based on prior experience and 
biologically significant effect size. For immunofluorescence, the sample size was typically 
~100 cells. Three biologic replicates were performed each with this sample size.
Data analysis was performed using Prism 6 (GraphPad). Statistical significance was 
determined using an ordinary one-way ANOVA with Dunnett’s multiple comparisons test 
with a single pooled variance when comparing multiple cell lines against the vector control 
or a two-tailed, unpaired t-test with Welch’s correction when comparing a single cell line 
with different chemical treatments.
High Resolution Imaging and Delta analysis—Samples were prepared as previously 
described35. Image acquisition was performed on a Nikon TE300 inverted microscope 
equipped with a Yokogawa CSU10 spinning disk confocal with image magnification 
yielding a 65 nm pixel size from the Orca ER cooled CCD camera and an 100X/1.4NA (Plan 
Apo) DIC oil immersion objective (Nikon). Sixty-five flame 3D stacks of pairs of red and 
green fluorescent images were obtained sequentially at 200 nm steps along the z-axis 
through the cell from coverslip surface using MetaMorph 6.1 software (Molecular Devices).
For each metaphase kinetochore pair, 3D centroid positions were measured with a 3D 
Gaussian fitting function as described previously36. The centroids of one color were 
projected to the axis defined by the centroids of the other color, and the Delta (average 
separation of the projection distance between the signals of red and green colors for theta 
pair) was calculated to correct for chromatic aberration. Mean Delta values were corrected 
for tilt of the face of the kinetochore relative to the axis between sister kinetochores.
Mass Spectrometry
Cell Culture—EGFP-Plk1as RPE1 cell lines stably expressing Flag-Plk1wt, Ch-Plk1aa, 
Flag-Plk1ΔC-Kif2c, Flag-Plk1ΔC-H2B, or Flag-Plk1ΔC-Dsn1 were split in half (2 chemical 
treatments/cell line) and cultured as above. At approximately 60% confluence, cells were 
synchronized in S-phase with 3 mM thymidine. After 24 h, cells were rinsed twice with 
Hank’s Balanced Salt Solution (HBSS), then replenished with fresh media containing 0.2 
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μg/ml nocodazole. After 18 h, 3-MB-PP1 (final concentration 10 mM) was added to all cells 
to inhibit Plk1as. To half of the cells, BI-2536 (final concentration 200 nM) was also added 
to inhibit the complementing Plk1wt allele. One hour later, mitotic cells were collected by 
shake-off, pelleted, rinsed x 1 with PBS, pelleted again, snap frozen in liquid nitrogen and 
stored at −80°C. A total of 10 cell pellets (5 cell lines ± BI-2536) were prepared in this 
manner.
MS Sample Preparation—Cell pellets were lysed in buffer (8 M urea, 50 mM Tris pH 
8.0, 100 mM CaCl2) containing dissolved protease and phosphatase inhibitor tablets (Roche) 
and then sonicated for 20 min. Protein concentrations were determined using a BCA kit 
(Thermo Pierce). Cell lysates were then reduced by addition of dithiothreitol (final 
concentration of 5 mM), incubated at 37°C for 45 min, and alkylated by adding 
iodoacetamide (15 mM final concentration). Next, lysates were incubated for 45 min in the 
dark at room temperature, and remaining iodoacetamide was quenched by bringing each 
lysate back to a final 5 mM dithiothreitol concentration. Next, lysates were diluted to a 1.5 
M urea concentration using a 50 mM Tris and 100 mM CaCl2 solution. Trypsin was added 
to each lysate in a 50:1 (protein: enzyme) ratio and digested overnight at ambient 
temperature. The 10 samples were desalted using 100 mg C18 Sep-Paks (Waters) and dried 
down using a vacuum centrifuge to obtain tryptically digested peptides. 1 mg of peptides for 
each of the 10 samples was incubated with 10-plex tandem mass tags (TMT) reagents 
(Thermo Scientific) for 3 h at room temperature. An aliquot of each sample was mixed in a 
1:1 ratio and run on an Orbitrap Elite mass spectrometer (Thermo Scientific) to ensure 
complete TMT peptide labeling. The 10 samples were mixed in a final 1:1 ratio across all 10 
TMT channels and desalted using a 500 mg C18 Sep-Pak (Waters) to produce a single 
pooled sample containing chemically labeled peptides from all 10 samples (5 cell lines ± 
BI-2536). The pooled sample was fractionated using Strong Cation Exchange (SCX) 
chromatography to produce 12 total peptide fractions, which were subsequently lyophilized 
and desalted. The resultant 12 peptide fractions were each enriched using Immobilized 
Metal Affinity Chromatography (IMAC) Ni-NTA magnetic agarose beads (Qiagen), leading 
to 12 final SCX fractionated enriched phosphopeptide and unenriched peptide fractions. 
Each fraction was dried down using a vacuum centrifuge and resuspended in 0.2% formic 
acid for mass spectrometry analyses.
Nano-LC-MS/MS Methods—Each sample was introduced to an Orbitrap Fusion mass 
spectrometer (Thermo Scientific) during a 90 min nano-liquid chromatography separation 
using a nanoAcquity UPLC (Waters). A “Top N” Fusion method was used to analyze eluting 
peptides, using a 60,000 resolving power survey scan followed by MS/MS scans collected at 
60,000 resolving power. Peptides were fragmented using higher-energy collisional 
dissociation (HCD) at a normalized collision energy of 35%. Phosphopeptide fractions were 
analyzed with 200 msec maximum injections times for MS scans and 120 ms maximum 
injection times for MS/MS scans, while unenriched fractions were analyzed with 100 ms 
maximum injections times for MS scans and 75 ms maximum injection times for MS/MS 
scans. Only peptides with charge states from +2 to +8 were selected for MS/MS with an 
exclusion duration of 30 s. The 12 phosphopeptide samples were run in duplicate.
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MS Data Analysis—Data was searched using Proteome Discoverer 1.4.1.14 (Thermo 
Fisher) with the Sequest search algorithm. Thermo RAW files were searched against a 
Homo sapiens target-decoy database (UniProt, downloaded 11/06/2014). Peptide and 
phosphopeptide datasets were searched using a 50 ppm precursor mass tolerance and 0.02 
Da fragment tolerance for b and y ions produced by HCD fragmentation. All fractions were 
searched with static carbadimomethyl of cysteine residues, static TMT 10-plex 
modifications of peptide N-termini and lysines, dynamic methionine oxidation, and dynamic 
TMT 10-plex modification of tyrosine residues. Phosphopeptide fractions were searched 
with additional dynamic phosphorylation modifications of serine, threonine, and tyrosine 
residues. Resulting peptide identifications were filtered to 1% false discovery rate (FDR) 
and exported to tab-delimited text files compatible with the COMPASS software suite51. 
COMPASS was used to obtain the 10-plex TMT protein and phosphopeptide quantitation for 
all the 12 peptide fractions and 12 phosphopeptide fractions. Peptides were mapped back to 
their parent proteins using COMPASS, and Phospho RS52 was used to localize 
phosphorylation to amino acid residues with a fragment tolerance of 0.02 Da automatically 
considering neutral loss peaks for HCD and considering a maximum of 200 maximum 
position isoforms per phosphopeptide. The raw 10-plex reporter ion intensities of localized 
phosphopeptide isoforms were log2 transformed and normalized against inhibited Plk1wt 
(+BI-2536) to obtain the relative phosphopeptide and protein quantitation for each cell line 
and condition. Phosphopeptides were considered targeted by each cell line (A) if the 
uninhibited condition exhibited a 2-fold increase over inhibited Plk1wt (i.e. AA vs. WT_BI) 
and (B) if the phosphopeptide abundance decreased by half when the cell line itself was 
inhibited by BI-2536 (i.e. AA vs. AA_BI) (Supplementary Dataset 1).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Plk1 signaling at the kinetochore requires binding via its PBD
(a) Schematic indicating orthogonal control of Plk1 alleles. (b) Schematic of 
complementation strategy. RPE1 cells expressing GFP-Plk1as (Plk1as) were stably infected 
with an empty Flag vector (Vector), Flag-tagged wild-type Plk1 (Plk1wt), or Plk1 with a 
wild-type kinase domain, but crippled Polo-box domain that delocalizes the protein (Plk1aa 
and Ch-Plk1aa). (c-f) Delocalized Plk1 fails to restore metaphase chromosome alignment or 
anaphase chromosome segregation when GFP-Plk1as is inhibited with 3-MB-PP1. (c) Graph 
shows average percentage (± SEM) of pre-anaphase mitotic cells at metaphase with fully 
aligned chromosomes for each cell line challenged with 500 nM 3-MB-PP1 (n=150 cells/
experiment; 3 independent experiments). (d) Representative maximal intensity projection 
micrographs from (c). Arrowheads indicate misaligned chromosomes. (e) Graph shows 
average percentage (± SEM) of anaphase cells with fully segregated chromosomes for each 
cell line challenged with DMSO (yellow bar) or 200 nM 3-MB-PP1 (cyan bars) (n=50 cells/
experiment; 4 independent experiments). (f) Representative maximal intensity projection 
micrographs from (e). Arrowheads indicate lagging chromosomes. *P<.05, ***P<0.0001 by 
one-way ANOVA or unpaired t-test; NS, not significant (panels c,e). Scale bars, 5 μm 
(panels d,f).
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Figure 2. High-resolution microscopy identifies discrete localization of endogenous Plk1 and 
kinetochore-tethered Plk1 constructs along the kinetochore-centromere axis
(a) High-resolution single plane images and Delta analysis of endogenous Plk1, CENP-U/50 
(also known as PBIP), and BubR1 used for kinetochore mapping in RPE1 cells. K-K 
indicates distances between the two centroids for CENP-I, CENP-U/50 or BubR1. (b) High-
resolution single plane images and Delta analysis of kinetochore-tethered Plk1 constructs. 
K-K indicates distances between the two centroids for the tethered constructs. (c) Map of 
kinetochore with summary of Delta measurements from panels a-b set relative to the N-
terminus of CENP-I (red). Endogenous proteins indicated in black and Plk1 fusion 
constructs in green. Positive values are outward toward the spindle microtubules and 
negative values are inward toward the inner centromere. *CENP-A position was reported 
previously35. Scale bars, 5 μm (panels a-b).
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Figure 3. 10-plex TMT phosphoproteomic analysis of Plk1 partitioned by locale within the KT 
axis
(a) Distribution of phosphopeptides (PPs) regulated by Plk1 activity. Out of a total of 11,407 
phosphopeptides encountered, 566 PPs were upregulated (> 2-fold increase +BI/−BI) and 
531 downregulated (> 2-fold decrease +/−BI) with exposure to the Plk1wt inhibitor, BI-2536. 
(b) Hypothetical distribution of Plk1wt (green) within the KT axis and partitioning function 
by locale within the KT axis (Dsn1-outer KT, Kif2c-outer KT/inner centromere, H2B-
chromatin) or by a delocalized control, (Ch-Plk1AA) (c) Identification of phosphopeptides 
(PPs) that are restored with each tethered Plk1 construct. Each dot on plot represents one of 
531 physiologically Plk1-regulated PPs (downregulated >2x with Plk1wt+BI). The x-axis 
displays its abundance relative to control (Plk1wt+BI) with values >2 indicating that 
phosphorylation is restored by the construct in question. The y-axis indicates the ratio PP/PP
+BI, with values >2 indicating that the restored PP is depleted with chemical inactivation of 
the regionally-restricted construct. Color-coded regions indicate the PPs that are reversibly 
restored with each regional construct. The Venn diagram at center illustrates the number of 
PPs that overlap by the distinct color-coded constructs.
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Figure 4. Restricting Plk1 activity along the kinetochore-centromere axis produces distinct 
phosphoproteomic and functional signatures
Cells expressing GFP-Plk1as and kinetochore-tethered Plk1 constructs were challenged with 
3-MB-PP1 (inhibits Plk1as) ± BI-2536 (inhibits Plk1wt/ Plk1ΔC constructs) and assayed for 
ability of constructs to rescue chromosome alignment during metaphase or segregation 
during anaphase. (a) Graphs show average percentage (± SEM) of pre-anaphase mitotic cells 
at metaphase with fully aligned chromosomes for each cell line (n≥100 cells/experiment; 3 
independent experiments). (b) Representative maximal intensity projection micrographs 
from (a). Arrowheads indicate misaligned chromosomes. (c) Graph shows average 
percentage (± SEM) of anaphase cells with fully segregated chromosomes for each cell line 
(n≥40 cells/experiment; at least 3 independent experiments). (d) Representative maximal 
intensity projection micrographs from (c). Arrowheads indicate lagging chromosomes. 
**P<0.005, ***P<0.0001 by one-way ANOVA or unpaired t-test; NS, not significant (panels 
a,c). Scale bars, 5 μm (panels b,d).
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Figure 5. Outer kinetochore tethering of Plk1 fails to restore chromosome alignment or 
segregation
(a-b) Cells expressing GFP-Plk1as and Kif2c localization mutants were challenged with 3-
MB-PP1 ± BI-2536 and assayed for ability of constructs to rescue chromosome alignment 
during metaphase or segregation during anaphase. (a) Graphs show average percentage (± 
SEM) of pre-anaphase mitotic cells at metaphase with fully aligned chromosomes for each 
cell line (n=150 cells/experiment; 3 independent experiments). (b) Graph shows average 
percentage (± SEM) of anaphase cells with fully segregated chromosomes for each cell line 
(n=50 cells/experiment; 4 independent experiments). (c-f) Cells expressing GFP-Plk1as and 
outer kinetochore-tethered Plk1 constructs were challenged with 3-MB-PP1 and assayed for 
ability of constructs to rescue chromosome alignment during metaphase or segregation 
during anaphase. (c) As in panel a (n=150 cells/experiment; 3 independent experiments). (d) 
Representative single-plane micrographs indicating kinetochore localization of Plk1 tethers 
in cells failing to restore chromosome alignment. (e) As in panel b (n≥30 cells/experiment; 4 
independent experiments). (f) Representative maximal intensity micrographs indicating 
localization of Plk1 tethers in cells failing to restore chromosome segregation. *P< 0.05, 
**P<0.005, ***P<0.0001 by one-way ANOVA or unpaired t-test; NS, not significant (panels 
a,b,c,e). Scale bars, 5 μm (panel d,f).
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Figure 6. Functional/proteomic signatures and a model for Plk1 activity in the kinetochore
(a) Phosphopeptides that are restored by constructs concordant with phenotypic rescue of 
chromosome alignment (left) and accurate chromosome segregation (right). 
Phosphopeptides (PPs) containing minimal Plk1 consensus are illustrated for each 
phenotype with bars illustrating difference between +/− BI-2536 for each construct. Left, 
phosphopeptides that are restored by Plk1wt and Kif2c only. Right, phosphopeptides that are 
restored with both H2B and Kif2c. (b) A model of Plk1 operation within the kinetochore 
could range from a highly dispersive operation where one binding partner provides access to 
all substrates (extreme left), versus focal operation, where Plk1 binds each substrate directly 
(extreme right). Our data support an intermediate model where Plk1 at each subcompartment 
can access elicit ~40 phosphorylation events, with minimal overlap between inner 
centromere, chromatin, and the outer kinetochore.
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